Research News

New therapeutic gel shows promise against cancerous tumors

New therapeutic gel shows promise against cancerous tumors

The lab of Zhen Gu, PhD, in the joint UNC-NC State biomedical engineering department developed a biodegradable hydrogel scaffold system to release chemotherapeutic and immunotherapeutic drugs at the tumor site.

New therapeutic gel shows promise against cancerous tumors - Read More…

Peanut allergy therapy proves effective during phase 3 clinical trial

Peanut allergy therapy proves effective during phase 3 clinical trial

Wesley Burks, MD, was a principal investigator on the phase 3 PALISADE trial to determine the efficacy of the AR101 oral immunotherapy developed by Aimmune Therapeutics for people allergic to peanuts.

Peanut allergy therapy proves effective during phase 3 clinical trial - Read More…

Phase I clinical trial shows promise as investigational drug for melanoma

Phase I clinical trial shows promise as investigational drug for melanoma

Three of 15 patients with BRAF-mutant melanoma had partial responses to an investigational compound in an early-stage study led by UNC Lineberger's Stergios Moschos, MD.

Phase I clinical trial shows promise as investigational drug for melanoma - Read More…